SLC1A5 and cancer: In particular, ASCT2 is highly up-regulated by MYC in several cancer types such as triple negative breast cancer, prostate cancer, and melanoma (reviewed in ref.3), where it imports glutamine into cells that is utilized to build biomass and enhance proliferation via mTORC1 (4).